VTRS

19.6301.26%
CM

Corinne M. Le Goff

Chief Commercial Officer

Dr. Corinne M. Le Goff, Pharm.D. MBA, serves as Chief Commercial Officer of Viatris Inc since April 15, 2024. Her responsibilities include oversight of Viatris’s global commercial function, including Developed Markets, Emerging Markets, Japan, Australia and New Zealand (“JANZ”) and Greater China and the Company's Global Commercial functions, including Global Strategic Marketing, Global Market Access and Value, Global Commercial Insights & Analytics and Global Commercial Development. She is an Independent Director of Euroapi S.A. since May 06, 2022 until January 11, 2023. She served as Independent Director at Acticor Biotech SAS since May 12, 2022 until January 2023. She was Chief Executive Officer and President of Imunon, Inc. from July 18, 2022 until March 15, 2024 and served as its Director from July 18, 2022 until March 15, 2024. She served as Chief Commercial Officer of Moderna, Inc. from January 2021 through January 2022. She served as Senior Vice President and General Manager of U.S. General Medicine at Amgen Inc. since March 2019. She was Senior Vice President of Global Product Strategy and Commercial Innovation at Amgen Inc. since June 2018 until March 2019 and was its Senior Vice President of the Europe Region from June 2015 to May 2018. She serves as Director at Longboard Pharmaceuticals Inc. since March 07, 2021. She was the Senior Vice President and Regional General Manager of Amgen Inc. since 2015. She also served as the SVP and General Manager of the U.S. Business Organization at Amgen, Inc. from March 2019 to January 2021. Before joining Amgen, she served as the President of Roche S.A.S, pharmaceuticals subsidiary of Roche in France and Global Product Strategy Head of Neuroscience & Rare Diseases. Dr. Le Goff has an in-depth knowledge of the pharmaceutical industry gained during her career working for different large leading companies in the pharmaceutical and biotechnology sectors where she held different functions and important positions. Before joining the Roche Group, she served as Senior Vice President of Strategy & Global Marketing Neurology & Rheumatology at Merck-Serono and Vice President of Empowered Regions Commercial Operations Empowered Regions at Sanofi- Aventis in the USA. She has been a Member of Supervisory Board at CFAO SA since October 28, 2014 until October 2020. Dr. Le Goff served on the board of directors of the Pacific Council on International Policy from October 2019 to December 2020. She earned a Pharm.D from the University of Paris Descartes and a Master's Degree from the University Panth?on Sorbonne. Dr. Le Goff held various positions within the Roche Group, a publicly traded Swiss multinational healthcare company, including President of Roche?s French affiliate from May 2012 to May 2015. She then completed her education with studies at different Business Schools in France and abroad. She holds an MBA in Marketing from La Sorbonne University, France and INSEAD.

Positions